Legal & General Group
JAZZ icon

Legal & General Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Legal & General Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5M Buy
145,528
+49,657
+52% +$8.68M 0.01% 741
2025
Q4 		$16.3M Sell
95,871
-24,006
-20% -$3.68M ﹤0.01% 932
2025
Q3 		$15.8M Sell
119,877
-65,947
-35% -$7.91M ﹤0.01% 966
2025
Q2 		$19.7M Buy
185,824
+18,675
+11% +$2.03M ﹤0.01% 862
2025
Q1 		$20.8M Buy
167,149
+38,375
+30% +$5.01M 0.01% 799
2024
Q4 		$15.9M Sell
128,774
-6,406
-5% -$755K ﹤0.01% 921
2024
Q3 		$15.1M Sell
135,180
-115,620
-46% -$12.7M ﹤0.01% 959
2024
Q2 		$26.8M Sell
250,800
-111,139
-31% -$12.2M 0.01% 745
2024
Q1 		$43.6M Sell
361,939
-31,295
-8% -$3.83M 0.01% 651
2023
Q4 		$48.4M Sell
393,234
-18,114
-4% -$2.26M 0.02% 640
2023
Q3 		$53.2M Sell
411,348
-26,838
-6% -$3.58M 0.02% 606
2023
Q2 		$54.3M Sell
438,186
-28,759
-6% -$3.87M 0.02% 616
2023
Q1 		$68.3M Sell
466,945
-13,783
-3% -$2.04M 0.02% 559
2022
Q4 		$76.6M Sell
480,728
-10,117
-2% -$1.48M 0.03% 525
2022
Q3 		$65.4M Sell
490,845
-1,718
-0.3% -$261K 0.03% 569
2022
Q2 		$76.8M Sell
492,563
-1,057
-0.2% -$163K 0.03% 556
2022
Q1 		$76.8M Buy
493,620
+45,373
+10% +$6.58M 0.02% 589
2021
Q4 		$57.1M Sell
448,247
-6,130
-1% -$806K 0.02% 659
2021
Q3 		$59.2M Sell
454,377
-21,837
-5% -$3.3M 0.02% 648
2021
Q2 		$84.6M Buy
476,214
+38,163
+9% +$6.61M 0.03% 579
2021
Q1 		$72M Sell
438,051
-6,698
-2% -$1.1M 0.03% 589
2020
Q4 		$73.4M Sell
444,749
-5,961
-1% -$888K 0.03% 561
2020
Q3 		$64.3M Buy
450,710
+52,203
+13% +$6.47M 0.03% 540
2020
Q2 		$44M Buy
398,507
+45,572
+13% +$5.04M 0.02% 602
2020
Q1 		$35.3M Buy
352,935
+8,495
+2% +$1.1M 0.02% 599
2019
Q4 		$51.4M Buy
344,440
+10,480
+3% +$1.43M 0.02% 590
2019
Q3 		$42.8M Buy
333,960
+5,301
+2% +$711K 0.02% 609
2019
Q2 		$46.9M Sell
328,659
-6,153
-2% -$827K 0.03% 591
2019
Q1 		$47.9M Buy
334,812
+72,784
+28% +$9.49M 0.03% 571
2018
Q4 		$32.5M Buy
262,028
+20,277
+8% +$3.01M 0.03% 580
2018
Q3 		$40.6M Buy
241,751
+456
+0.2% +$78.4K 0.03% 573
2018
Q2 		$41.6M Buy
241,295
+4,268
+2% +$698K 0.03% 554
2018
Q1 		$35.8M Sell
237,027
-139
-0.1% -$20.4K 0.03% 593
2017
Q4 		$31.9M Buy
237,166
+2,499
+1% +$347K 0.02% 605
2017
Q3 		$34.3M Buy
234,667
+2,829
+1% +$428K 0.03% 589
2017
Q2 		$36.1M Buy
231,838
+5,493
+2% +$840K 0.03% 565
2017
Q1 		$32.8M Buy
226,345
+3,594
+2% +$468K 0.03% 582
2016
Q4 		$24.3M Buy
+222,751
New +$24.8M 0.02% 605

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Legal & General Group's JAZZ Position: Q1 2026 in Review

Legal & General Group increased its Jazz Pharmaceuticals (JAZZ) stake by 52% in Q1 2026, buying an estimated $8.68M and bringing the position to 145,528 shares worth $27.5M. The position accounts for 0.01% of the portfolio, ranked #741.

Legal & General Group first reported a position in JAZZ in Q4 2016 and has held it in 38 quarters since. The position peaked at $84.6M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Legal & General Group held 145,528 shares of Jazz Pharmaceuticals worth $27.5M as of Q1 2026.
  • Legal & General Group bought 49,657 Jazz Pharmaceuticals shares in Q1 2026, an estimated $8.68M.
  • Jazz Pharmaceuticals made up 0.01% of Legal & General Group's portfolio in Q1 2026, its #741 holding.
  • Legal & General Group first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 38 quarters since.
  • Legal & General Group's Jazz Pharmaceuticals position peaked at $84.6M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.